/PRNewswire/ Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that it will hold an in-person and virtual.
STOCKHOLM, May 16, 2024 /PRNewswire/ Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that it will hold an in-person and virtual R&D day
Agenda for Calliditas virtual R&D Day on January 20, 2021
News provided by
Share this article
Calliditas Therapeutics AB (publ) ( Calliditas ) (Nasdaq OMX - CALTX) (NASDAQ - CALT)
today announced the program for the upcoming virtual R&D Day for investors, analysts and journalists on January 20, 2021, which will take place between 1pm and 5pm CET. The R&D Day will feature presentations from executive management and Key Opinion Leaders and will be webcast live and accessible at:
1:00pm
Professor Jonathan Barratt
CMO Dr Richard Phillipson
Professor Jonathan Barratt
2:20pm
2:40pm
Head of North America Commercial, Andrew Udell, & Vice President Market Access, Christopher Ngai